July 1, 2026 · Form 4 insider transaction
KREHER NERISSA bought 37,910 shares of Xeris Biopharma Holdings, Inc. at $8.00 per share, a transaction worth $303.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service on the Company's Board of Directors through such vesting date.